About UsOur SciencePipelineNewsContactMeet our founders →
Home/News
Newsroom

News & announcements

Company news, financing milestones, and clinical program updates from cAMPfield Therapeutics.

Jun 18, 2026

cAMPfield Launches With $180 Million Series A to Develop Oral PDE4B Inhibitor for IBD

Financing · Company
Read →

Media inquiries

For interviews, assets, or background, reach the cAMPfield communications team.

contact@campfieldtx.com →
© 2026 cAMPfield Therapeutics, Inc.Privacy · Terms · Forward-Looking Statements